Temozolomide Bests Nivolumab in Glioblastoma With Unmethylated MGMT Promoter
Overall and progression-free survival were superior with temozolomide.
Overall and progression-free survival were superior with temozolomide.
Researchers sought to develop and validate an MRI radiomics prediction model through a machine learning-based method to predict the survival of patients with glioma.
Maternal hormonal contraception use is not associated with central nervous system (CNS) tumors among children.
Researchers sought to evaluate the activity and safety of dabrafenib plus trametinib in adult patients with recurrent or progressive BRAF V600E -mutation–positive high-grade and low-grade glioma.
The researchers sought to assess the safety and efficacy of cabozantinib to treat brain metastases in patients with metastatic renal cell carcinoma.
From 2008 to 2017, the incidence of malignant brain tumors decreased for all ages combined, but increased among children and adolescents.
Nurse researchers defined the prevalence and potential risk mitigation for acute ischemic stroke in brain tumor survivors.
Researchers applied a machine learning strategy in a longitudinal analysis of clinical features linked to neurofibromatosis type 1 in pediatric patients.
Surgical treatment of intracranial meningioma (IM) should be considered even in patients over the age of 80 years.
The maker of the expensive brain cancer drug Gleostine has removed it from the Medicare drug rebate program.